ArticleJournal of virology2026
EV-D68 exploits clathrin-mediated endocytosis and compensatory macropinocytosis for cellular entry.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Despite growing health concerns about enterovirus D68 (EV-D68), its cellular entry mechanisms remain incompletely understood. In this study, we investigated the endocytic pathways exploited by the sialic acid-dependent EV-D68 TW-02795-2014 strain using pharmacological inhibitors, siRNA-mediated knockdown, dominant-negative constructs, and electron microscopic analysis. Chemical inhibition of clathrin-mediated endocytosis (CME), macropinocytosis, endosomal acidification, and other endocytic pathways reduced viral entry and protein expression, suggesting the involvement of multiple routes in viral entry. Co-localization of EV-D68 with clathrin and the effects of CME inhibitors supported CME as a major entry route. However, siRNA knockdown of CME components in RD cells inhibited the cellular uptake of transferrin, yet had no significant impact on EV-D68 infection. This was also seen in A549 cells. Notably, CME disruption by clathrin knockdown led to Rac1 upregulation and increased macropinocytosis, which facilitated EV-D68 entry. Transmission electron microscopy revealed membrane-associated EV-D68 particles organized in clusters underneath the cell surface during infection, potentially undergoing bulk internalization. In contrast, purified virions lacking membranous material strictly required CME for successful infection. These findings reveal a dual entry strategy: single (membrane-free) EV-D68 particles utilize CME, while membrane-associated virions access host cells via macropinocytosis, particularly under conditions of CME inhibition. This study highlights the complexity of EV-D68 endocytosis and underscores the importance of compensatory mechanisms in viral uptake.IMPORTANCEUnderstanding how EV-D68 enters host cells is crucial for developing antiviral strategies. This study uncovers a dual-entry mechanism used by a sialic acid-dependent EV-D68 strain: clathrin-mediated endocytosis (CME) for single virus particles, and macropinocytosis as an alternative route for membrane-associated particles or under conditions where CME is impaired. Notably, disruption of CME induces a compensatory upregulation of macropinocytosis, mediated by increased Rac1. These findings challenge prior assumptions of a singular viral entry pathway and emphasize the need to consider endocytic plasticity when designing antiviral interventions targeting EV-D68 or similar viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.